Quick Answer
SANUWAVE Health, Inc. reported R&D Expense of $1.35 million for fiscal year 2025.
SANUWAVE Health, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $1.35M | +101.0% |
| 2024 | $673.0K | +16.2% |
| 2023 | $579.0K | +2.1% |
| 2022 | $567.0K | -48.5% |
| 2021 | $1.10M | -11.6% |
| 2020 | $1.25M | +5.4% |
| 2019 | $1.18M | +20.4% |
| 2018 | $981.7K | -24.1% |
| 2017 | $1.29M | +14.5% |
| 2016 | $1.13M | -48.1% |
| 2015 | $2.17M | -27.6% |
| 2014 | $3.00M | +30.7% |
| 2013 | $2.30M | +30.3% |
| 2012 | $1.76M | -35.5% |
| 2011 | $2.73M | -29.6% |
| 2010 | $3.88M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $345.0K | +114.3% | +77.8% |
| June 30, 2025 | $194.0K | -0.5% | -6.7% |
| March 31, 2025 | $208.0K | +27.6% | +29.2% |
| September 30, 2024 | $161.0K | -2.4% | -17.4% |
| June 30, 2024 | $195.0K | +40.3% | +19.6% |
| March 31, 2024 | $163.0K | +24.4% | -1.2% |
| September 30, 2023 | $165.0K | +5.1% | +18.7% |
| June 30, 2023 | $139.0K | -18.7% | +6.1% |
- SANUWAVE Health, Inc. showed an increase of +101.0% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, SANUWAVE Health, Inc.’s r&d expense has declined by 65.1% (from $3.88 million to $1.35 million).
- The most recent figure is from SANUWAVE Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: